Emergent Biosolutions (EBS)'s 30-day implied volatility (IV30) was 65.0% at the close on November 5, 2026, down from 65.4% the day before, against a 52-week range of 40.2% to 119.2%. Its 20-day historical volatility was 75.6%.
Data as of November 5, 2026.